Jazz Pharmaceuticals Correlations
| J7Z Stock | EUR 116.85 1.15 0.97% |
The current 90-days correlation between Jazz Pharmaceuticals plc and Novo Nordisk AS is 0.13 (i.e., Average diversification). The correlation of Jazz Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Jazz Pharmaceuticals Correlation With Market
Modest diversification
The correlation between Jazz Pharmaceuticals plc and DJI is 0.28 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Jazz Pharmaceuticals plc and DJI in the same portfolio, assuming nothing else is changed.
Jazz |
The ability to find closely correlated positions to Jazz Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Jazz Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Jazz Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Jazz Pharmaceuticals plc to buy it.
Moving together with Jazz Stock
| 0.79 | TM2 | Sydbank AS | PairCorr |
| 0.83 | 5F3 | JINS HOLDINGS INC | PairCorr |
| 0.63 | SON1 | Sony Group Corp | PairCorr |
| 0.7 | 92I | ROMERIKE SPAREBANK | PairCorr |
| 0.91 | BFP | BBVA Banco Frances | PairCorr |
| 0.81 | AQHE | Event Hospitality | PairCorr |
| 0.92 | UFH | US FOODS HOLDING | PairCorr |
| 0.89 | NT4 | Northern Trust | PairCorr |
| 0.88 | FFH | Fifth Third Bancorp | PairCorr |
| 0.92 | PNP | PNC Financial | PairCorr |
| 0.9 | QAN | Qantas Airways | PairCorr |
| 0.61 | D2V | PARKEN Sport Enterta | PairCorr |
| 0.91 | AF4 | HANOVER INSURANCE | PairCorr |
| 0.92 | 2WY | Wyndham Hotels Resorts | PairCorr |
| 0.63 | C6TB | CHINA BANK ADR20 | PairCorr |
| 0.91 | PTX | Palantir Technologies | PairCorr |
| 0.89 | WX1 | Acadia Realty Trust | PairCorr |
| 0.9 | PCG6 | PG E P6 | PairCorr |
| 0.91 | LIE | Sun Life Financial | PairCorr |
| 0.84 | EQN2 | Equinix | PairCorr |
Moving against Jazz Stock
| 0.91 | 0QF | Moderna | PairCorr |
| 0.82 | YHA | Yamaha Split | PairCorr |
| 0.8 | MBG | Mercedes Benz Group | PairCorr |
| 0.63 | NOVA | Novo Nordisk AS | PairCorr |
| 0.63 | CSJ | CSL Limited | PairCorr |
| 0.61 | 893 | MITSUBISHI KAKOKI | PairCorr |
| 0.6 | CSJA | CSL LTD SPONADR | PairCorr |
| 0.48 | 5FV | YAOKO LTD | PairCorr |
| 0.63 | AXI | Atos SE | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Jazz Stock performing well and Jazz Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Jazz Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NOVA | 1.38 | (0.29) | 0.00 | 4.97 | 0.00 | 2.94 | 6.32 | |||
| CSJA | 1.03 | (0.13) | 0.00 | (0.34) | 0.00 | 2.38 | 6.98 | |||
| CSJ | 0.95 | (0.10) | 0.00 | (2.14) | 0.00 | 2.11 | 4.47 | |||
| MBG | 1.09 | (0.04) | 0.00 | (0.30) | 0.00 | 1.98 | 9.12 | |||
| VX1 | 1.39 | (0.17) | 0.00 | (3.32) | 0.00 | 3.36 | 20.51 | |||
| 0QF | 2.43 | (0.62) | 0.00 | (0.90) | 0.00 | 4.00 | 15.59 | |||
| 1FW1 | 3.92 | 0.83 | 0.17 | (2.94) | 3.96 | 11.85 | 28.36 | |||
| 22UA | 2.16 | 0.14 | 0.04 | 1.43 | 2.72 | 5.82 | 14.85 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Jazz Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Jazz Pharmaceuticals Corporate Management
Elected by the shareholders, the Jazz Pharmaceuticals' board of directors comprises two types of representatives: Jazz Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Jazz. The board's role is to monitor Jazz Pharmaceuticals' management team and ensure that shareholders' interests are well served. Jazz Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Jazz Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert MD | Ex RD | Profile | |
| Finbar Larkin | VP Operations | Profile | |
| George Eliades | Sr Officer | Profile | |
| Patricia Carr | VP Officer | Profile | |
| Heidi Manna | VP Officer | Profile | |
| Neena JD | Ex Officer | Profile |